FONDAZIONE IRCCS ISTITUTO NAZIONALE DEI TUMORI

Contract research organisation to run a multicentre clinical trial in Milan, Italy

The buyer, a cancer research institute in Milan, wants a contract research organisation (CRO) to manage a randomised, multicentre Phase 3 clinical study on kidney cancer (metastatic renal cell carcinoma). The study is called ComboSeq. The tender is an open procedure run on the Sintel platform. The notice also includes an ex-post accession clause of 300% for consortium bodies, including the buyer.